eFFECTOR Therapeutics Inc... (EFTR)
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -35.81M | -22.66M | 15.80M | 14.21M | -29.74M |
| Depreciation & Amortization | 111.00K | 53.00K | 24.00K | 160.00K | 307.00K |
| Stock-Based Compensation | 4.59M | 5.33M | 8.66M | 499.00K | 646.00K |
| Other Working Capital | 830.00K | 1.72M | -393.00K | -573.00K | 1.80M |
| Other Non-Cash Items | -130.00K | -11.30M | -48.59M | 122.00K | 2.10M |
| Deferred Income Tax | n/a | n/a | -539.00K | -333.00K | -1.99M |
| Change in Working Capital | 1.69M | 2.68M | -238.00K | -824.00K | 1.07M |
| Operating Cash Flow | -29.55M | -25.90M | -24.89M | 13.84M | -27.60M |
| Capital Expenditures | -97.00K | -192.00K | -42.00K | -154.00K | -4.00K |
| Acquisitions | n/a | 17.67M | 607.00K | n/a | 88.00K |
| Purchase of Investments | -17.17M | -52.42M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 31.75M | 34.75M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -17.67M | 607.00K | n/a | 88.00K |
| Investing Cash Flow | 14.48M | -17.86M | 565.00K | -154.00K | 84.00K |
| Debt Repayment | n/a | n/a | 5.89M | -2.00M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | -86.00K |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 56.00K | -34.00K | 52.91M | 108.00K | 20.24M |
| Financial Cash Flow | 21.23M | 2.77M | 58.81M | -1.89M | 20.24M |
| Net Cash Flow | 6.17M | -40.99M | 34.49M | 11.79M | 3.43M |
| Free Cash Flow | -29.65M | -26.09M | -24.93M | 13.68M | -27.60M |